<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
	<TITLE>$titleTag</TITLE>
<STYLE type="text/css">
   subtoolbar {border-top-width: 0px; border-top-style: none;}


   
 </STYLE>	
</head>
<body>
	
	<table width="940" height="496" border="0" align="center" cellpadding="0" cellspacing="0">
		<tr>
			<td height="489" align="right" valign="top"><SPAN><BR><INPUT type="BUTTON" name="BUTTON" value="< BACK" onclick="javascript: history.go(-1)" /></SPAN><BR>
			<table width="100%">
				<tr valign="top" align="left" style="color:#0066FF">
					<th width="33%">j100851</th>
					<th width="33%">i25662795</th>
					<th width="33%"><A HREF='http://phoenix.jstor.org/Phoenix/toc/secure/issue.html?workType=mod&journalId=10.2307/j100851&issueId=10.2307_i25662795' target='_blank'>PHX Link</A></th>
				</tr>
			</table>
			<P align='left' style='color:#993300'><B><u>10.2307/25662816</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Hypertensive disorders of pregnancy are more frequent in primiparous women, but may be more severe in multiparas. We examined trends in stillbirth and neonatal mortality related to pregnancy-induced hypertension (PIH), and explored whether mortality varied by parity and maternal race.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Hypertensive disorders of pregnancy are more frequent in primiparous women, but may be more severe in multiparas. We examined trends in stillbirth and neonatal mortality related to pregnancy-induced hypertension (PIH), and explored whether mortality varied by parity and maternal race.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We carried out a population-based study of 57 million singleton live births and stillbirths (24–46 weeks' gestation) in the United States between 1990 and 2004. We estimated rates and adjusted odds ratios (ORs) of stillbirth and neonatal death in relation to PIH, comparing births in 1990–1991 with 2003–2004.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: PIH increased from 3.0% in 1990–1991 to 3.8% in 2003–2004. In both periods, PIH was associated with a higher risk of stillbirth and neonatal death. We explored this in more detail in 2003–2004, and observed that the increased risk of PIH-related stillbirth was higher in women having their second or higher-order births (OR = 2.2 [95% confidence interval = 2.1–2.4]) compared with women having their first birth (1.5 [1.4–1.6]). Patterns were similar for neonatal death (1.3 [1.2–1.4] in first and 1.6 [1.5–1.8] in second or higher-order births). Among multiparas, the association between PIH and stillbirth was stronger in black women (2.9 [2.7–3.2]) than white women (2.0 [1.8–2.1]).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: A substantial burden of stillbirth and neonatal mortality is associated with PIH, especially among multiparous women, which may be due to more severe PIH, or to a higher burden of underlying disease.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662814</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: It has been suggested that cryptorchidism and hypospadias may be the result of a common pathologic pathway that causes testicular dysgenesis during fetal life. To address the potential heritability of this pathway, we specifically examined to what extent a family history of cryptorchidism increases the risk of developing hypospadias and vice versa.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: It has been suggested that cryptorchidism and hypospadias may be the result of a common pathologic pathway that causes testicular dysgenesis during fetal life. To address the potential heritability of this pathway, we specifically examined to what extent a family history of cryptorchidism increases the risk of developing hypospadias and vice versa.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: By using Danish health registers, we identified 27,762 boys diagnosed with cryptorchidism and 4832 boys diagnosed with hypospadias in a cohort of 1,018,517 boys born during 1977–2005. Using binomial log-linear regression, we estimated risk ratios of cryptorchidism and hypospadias in male twin pairs and first-, second-, and third-degree relatives with a family history of hypospadias and cryptorchidism, respectively.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: After adjusting for birth period and personal hypospadias/cryptorchidism status, there was little evidence of increased risk of cryptorchidism given a family history of hypospadias, and vice versa. However, cryptorchidism and hypospadias was associated on an individual level.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: We found no persuasive evidence that a family history of hypospadias increases the risk of cryptorchidism and vice versa. Thus, we found no support for shared heritability of hypospadias and cryptorchidism.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662801</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Regular exercise has been associated with a 40%–80% reduction in risk for endometriosis in several case-control studies. However, women experiencing symptoms prior to their diagnosis may be less likely to exercise than healthy controls, thus biasing the observed association.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Regular exercise has been associated with a 40%–80% reduction in risk for endometriosis in several case-control studies. However, women experiencing symptoms prior to their diagnosis may be less likely to exercise than healthy controls, thus biasing the observed association.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Using data collected from the Nurses' Health Study II, a prospective cohort study of premenopausal US nurses that began in 1989, we have attempted to clarify this relation. Data are updated every 2 years with follow-up for these analyses through 2001. In 1989, 1991, and 1997 women reported average amount of time per week engaging in various physical activities. A metabolic equivalent (MET) score was assigned to each activity, and these were summed to estimate total activity.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: A total of 102,197 premenopausal women contributed 996,422 person-years of follow-up with 2703 cases of laparoscopically confirmed endometriosis. After adjusting for BMI at age 18, current BMI, smoking, parity, infertility status, oral contraceptive use, age at menarche, and menstrual cycle length and pattern in college, we observed only a slight reduction in the incidence of endometriosis, comparing the highest level of activity (?42 MET hours/week) to the lowest (<3 MET hours/week) (rate ratio = 0.89 [95% confidence interval = 0.77–1.03]). The association was limited to participants with no past or concurrent infertility (P = 0.002, test for heterogeneity). No associations were seen with inactivity.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: In this first prospective assessment, we did not find evidence of the strong inverse association previously reported, although we cannot rule out a modest inverse association.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662815</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Delivery of a boy has been reported to increase a woman's risk of recurrent miscarriage in subsequent pregnancies. We explored whether delivery of boys similarly increases the risk of a subsequent stillbirth.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Delivery of a boy has been reported to increase a woman's risk of recurrent miscarriage in subsequent pregnancies. We explored whether delivery of boys similarly increases the risk of a subsequent stillbirth.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We identified all Danish women delivering their first child (singleton) between 1980 and 1998 (n = 499,731) using the Danish Birth Registry. These women had subsequent singleton births through 2004 (n = 558,314). We assessed the risk of stillbirth conditional on sex of prior children.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The risk of stillbirth was increased by 12% after deliver of boys compared with girls (relative risk = 1.12 [95% confidence interval = 1.02–1.23]). This association did not appear to be explained by maternal confounders.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Stillbirth risk appears to be slightly higher among the pregnancies of women who have previously delivered a boy. One possible mechanism is maternal immune response to male-specific minor histocompatibility antigens initiated during pregnancies with boys.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662802</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Viliuisk encephalomyelitis is a disorder that starts, in most cases, as an acute meningoencephalitis. Survivors of the acute phase develop a slowly progressing neurologic syndrome characterized by dementia, dysarthria, and spasticity. An epidemic of this disease has been spreading throughout the Yakut Republic of the Russian Federation. Although clinical, neuropathologic, and epidemiologic data suggest infectious etiology, multiple attempts at pathogen isolation have been unsuccessful.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Viliuisk encephalomyelitis is a disorder that starts, in most cases, as an acute meningoencephalitis. Survivors of the acute phase develop a slowly progressing neurologic syndrome characterized by dementia, dysarthria, and spasticity. An epidemic of this disease has been spreading throughout the Yakut Republic of the Russian Federation. Although clinical, neuropathologic, and epidemiologic data suggest infectious etiology, multiple attempts at pathogen isolation have been unsuccessful.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Detailed clinical, pathologic, laboratory, and epidemiologic studies have identified 414 patients with definite Viliuisk encephalomyelitis in 15 of 33 administrative regions of the Yakut Republic between 1940 and 1999. All data are documented in a Registry.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: The average annual Viliuisk encephalomyelitis incidence rate at the height of the epidemic reached 8.8 per 100,000 population and affected predominantly young adults. The initial outbreak occurred in a remote isolated area of the middle reaches of Viliui River; the disease spread to adjacent areas and further in the direction of more densely populated regions. The results suggest that intensified human migration from endemic villages led to the emergence of this disease in new communities. Recent social and demographic changes have presumably contributed to a subsequent decline in disease incidence.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Based on the largest known set of diagnostically verified Viliuisk encephalomyelitis cases, we demonstrate how a previously little-known disease that was endemic in a small indigenous population subsequently reached densely populated areas and produced an epidemic involving hundreds of persons.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662821</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Analysts of epidemiologic data often contend with the problem of estimating the independent effects of many correlated exposures. General approaches include assessing each exposure separately, adjusting for some subset of other exposures, or assessing all exposures simultaneously in a single model such as semi-Bayes modeling. The optimal strategy remains uncertain, and it is unclear to what extent different reasonable approaches influence findings. We provide an empirical comparison of results from several modeling strategies.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Analysts of epidemiologic data often contend with the problem of estimating the independent effects of many correlated exposures. General approaches include assessing each exposure separately, adjusting for some subset of other exposures, or assessing all exposures simultaneously in a single model such as semi-Bayes modeling. The optimal strategy remains uncertain, and it is unclear to what extent different reasonable approaches influence findings. We provide an empirical comparison of results from several modeling strategies.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: In an occupational case-control study of lung cancer with 184 exposure substances, we implemented 6 modeling strategies to estimate odds ratios for each exposure-cancer association. These included one-exposure-at-a-time models with various confounder selection criteria (such as a priori selection or a change-in-the-estimate criterion) and semi-Bayes models, one version of which integrated information on previous evidence and chemical properties.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: While distributions of odds ratios were broadly similar across the 6 analytic strategies, there were some differences in point estimates and in substances manifesting statistically significant odds ratios, particularly between strategies with few or no occupational covariates and those with many. Semi-Bayes models produced fewer statistically significant odds ratios than other methods. A simple semi-Bayes model that shrank all the 184 estimates to a common mean yielded nearly identical results to one that integrated considerable prior information.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Different modeling strategies can lead to different results. Considering the conceptual and pragmatic difficulties of identifying confounders, these results suggest that it would be unwise to place uncritical reliance on any single strategy.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662803</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: No studies have examined human papillomavirus (HPV) infections among couples early in their sexual relationships when transmission is most likely. Our objective was to describe the distribution of HPV infections among recently formed couples, using the partnership as the unit of analysis.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: No studies have examined human papillomavirus (HPV) infections among couples early in their sexual relationships when transmission is most likely. Our objective was to describe the distribution of HPV infections among recently formed couples, using the partnership as the unit of analysis.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Women aged 18–24 years attending a university or junior college in Montreal enrolled in a longitudinal study with their new male partners. Self-collected vaginal swabs and clinician-collected swabs from the penis and scrotum were tested for 36 HPV genotypes. Participants self-reported sexual behavior in computerized questionnaires. We analyzed patterns of genital HPV infection in 263 couples using data obtained at enrollment.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Couples had engaged in vaginal sex for a median of 3.9 months. HPV was detected in 64% (169/263) of couples. In 41% (109/263), both partners harbored the same HPV type—nearly 4 times more than expected if HPV status of partners were uncorrelated. There were 583 type-specific HPV infections among 169 couples for whom at least one partner was infected. Of these, 42% were of the same type for both partners (95% confidence interval = 36%–47%). This rose from 25% among those engaging in vaginal sex for less than 2 months to 68% among those at 5 to 6 months.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Although HPV is common, detection of the same type in persons initiating a sex relationship would be rare given type-specific prevalence rates. The high degree of concordance we found suggests a high probability of transmission.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662812</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: We conducted a meta-analysis of occupational studies of trichloroethylene-exposed workers to evaluate patterns of associations by study design, exposure assessment methods, and occupational groups.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: We conducted a meta-analysis of occupational studies of trichloroethylene-exposed workers to evaluate patterns of associations by study design, exposure assessment methods, and occupational groups.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Estimates of summary relative risk (RR) were calculated using inverse-variance weighting methods. Cohort studies were classified as group I or group II, depending on quality of the study design and exposure assessment procedures. We conducted sensitivity analyses to examine sources of heterogeneity.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Across all studies meeting our inclusion criteria (n = 23), the summary RR was 1.42 (95% confidence interval = 1.17–1.77), with heterogeneity present (test for heterogeneity: P = 0.001). After removal of 3 outlier studies, the summary RR for the remaining studies was 1.24 (1.06–1.45 (test for heterogeneity: P = 0.616)). The summary RR for studies of workers who were identified as more likely exposed to trichloroethylene (group I studies) was 1.34 (1.06–1.68). With outlier studies removed, the group II summary RR estimates for the cohort studies was 0.88 (0.58–1.33) and for the case-control studies was 1.33 (1.02–1.73). The summary RR for studies that used biomarkers to classify exposure (n = 3) was 1.02 (0.59–1.77) and for studies of aerospace/aircraft workers (n = 7) was 1.14 (0.84–1.57).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Positive associations were observed across various study groups. However, considerations of unmeasured potential confounding, lack of quantitative exposure assessment and lack of exposure-response patterns limit epidemiologic insight into the role of trichloroethylene exposure and its potential causal association with kidney cancer.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662804</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: It is unclear whether a linear relationship is an appropriate description of the association between income and biologic markers of coronary heart disease risk. Stronger associations at certain levels of income would have implications for underlying mechanisms.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: It is unclear whether a linear relationship is an appropriate description of the association between income and biologic markers of coronary heart disease risk. Stronger associations at certain levels of income would have implications for underlying mechanisms.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: The study is based on a healthy sample of 25–64 year olds (n = 14,022) from a nationally representative cross-sectional study (the 1988–1994 United States Third National Health and Nutrition Examination Survey). We use regression splines to model the shape of the association between income and 8 biologic markers for coronary heart disease risk, controlling for age, race/ethnicity, marital status, and education.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Substantial income-biomarker associations were found for 5 outcomes among women (HDL cholesterol, triglycerides, C-reactive protein, systolic blood pressure, and venous blood lead) and for 3 outcomes among men (HDL cholesterol, triglycerides, and venous blood lead). The most common shapes of association were a stronger association at lower income levels and a greater risk level of biomarker near median income.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: We find that the associations of income with biologic risk markers are often nonlinear. The differences in the shape of association suggest there are multiple pathways through which income is associated with coronary heart disease risk.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662813</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Arsenic in drinking water is associated with kidney cancer. Beginning in 1958, a region of Chile experienced a rapid onset of high arsenic exposure in drinking water, followed by sharp declines when water treatment plants were installed in 1971.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Arsenic in drinking water is associated with kidney cancer. Beginning in 1958, a region of Chile experienced a rapid onset of high arsenic exposure in drinking water, followed by sharp declines when water treatment plants were installed in 1971.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: For the years 1950–1970, we obtained mortality data from death certificates for an exposed region and an unexposed region in Chile. We obtained computerized mortality data for all of Chile for 1971–2000.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Kidney cancer risks for the exposed region compared with the unexposed started to increase about 10 years after high arsenic exposures began in 1958. The peak kidney cancer mortality rate ratio (RR) was 3.4 (95% confidence interval = 2.2–5.1) for men in 1981–1985, with subsequent declines to 1.6 (1.2–2.1) by 1996–2000. Mortality RRs among women were 2.9 (1.8–4.7) in 1981–1985 but remained high longer than for men, increasing further to a RR of 4.4 (3.0–6.4) in 1991–1995. Early-life exposure resulted in an increased RR of 7.1 (3.1–14) for young adults aged 30–39 years, born just before or during the high exposure period.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: This study shows a latency pattern of increased mortality from kidney cancer, continuing for at least 25 years after the high exposures began to decline. Early life exposure resulted in markedly higher kidney cancer mortality in young adults.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662805</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Little research has investigated the health effects of particulate exposure from bushfires (also called wildfires, biomass fires, or vegetation fires), and these exposures are likely to increase, for several reasons. We investigated associations of daily mortality and hospital admissions with bushfire-derived particulates, compared with particulates from urban sources in Sydney, Australia from 1994 through 2002.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Little research has investigated the health effects of particulate exposure from bushfires (also called wildfires, biomass fires, or vegetation fires), and these exposures are likely to increase, for several reasons. We investigated associations of daily mortality and hospital admissions with bushfire-derived particulates, compared with particulates from urban sources in Sydney, Australia from 1994 through 2002.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: On days with the highest particulate matter (PM)?? concentrations, we assumed PM?? was due primarily to bushfires. We calculated the contribution of bushfire PM?? on these days by subtracting the background PM?? concentration estimated from surrounding days. We assumed PM?? on the remaining days was from usual urban sources. We implemented a Poisson model, with a bootstrap-based methodology, to select optimum smoothed covariate functions, and we estimated the effects of bushfire PM?? and urban PM??, lagged up to 3 days.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: We identified 32 days with extreme PM?? concentrations due to bushfires or vegetation-reduction burns. Although bushfire PM?? was consistently associated with respiratory hospital admissions, we found no consistent associations with cardiovascular admissions or with mortality. A 10 ?g/m³ increase in bushfire PM?? was associated with a 1.24% (95% confidence interval = 0.22% to 2.27%) increase in all respiratory disease admissions (at lag 0), a 3.80% (1.40% to 6.26%) increase in chronic obstructive pulmonary disease admissions (at lag 2), and a 5.02% (1.77% to 8.37%) increase in adult asthma admissions (at lag 0). Urban PM?? was associated with all-cause and cardiovascular mortality, as well as with cardiovascular and respiratory hospital admission, and these associations were not influenced by days with extreme PM?? concentrations.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: PM?? from bushfires is associated primarily with respiratory morbidity, while PM?? from urban sources is associated with cardiorespiratory mortality and morbidity.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662810</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Body mass index (BMI) has been linked with both increased and decreased risk of suicide attempts and deaths.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Body mass index (BMI) has been linked with both increased and decreased risk of suicide attempts and deaths.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: In a prospective cohort study of 1.1 million adults, participants reported their anthropometric and other characteristics in 1982. Participants were followed for cause-specific mortality through 2004.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: A total of 2231 participants died of suicide during 21.6 million person-years of follow-up. Compared with a BMI of 18.5–22.9 kg/m², adjusted hazard ratios for completed suicide were 0.99 (95% confidence interval = 0.72–1.37), 0.78 (0.69–0.88), 0.73 (0.65–0.82), 0.72 (0.62–0.83), 0.77 (0.65–0.92), and 0.55 (0.36–0.83) for BMI values <18.5, 23.0–24.9, 25.0–27.4, 27.5–29.9, 30.0–34.9, and ?35.0 kg/m², respectively. The relationship was consistent among men and women and across geographic regions, but was limited to married individuals (test for interaction, P = 0.009).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: The risk of death from suicide is inversely related to BMI in middle-aged and older adults.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662806</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Several epidemiologic studies suggest a slightly increased risk of type 2 diabetes in relation to background levels of dioxins. Little is known about how serum dioxins might affect insulin resistance, a hallmark of type 2 diabetes. We examined the association between exposure to dioxins and insulin resistance.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Several epidemiologic studies suggest a slightly increased risk of type 2 diabetes in relation to background levels of dioxins. Little is known about how serum dioxins might affect insulin resistance, a hallmark of type 2 diabetes. We examined the association between exposure to dioxins and insulin resistance.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We investigated 1234 nondiabetic persons living near a deserted pentachlorophenol factory. Using high-resolution gas chromatography/high-resolution mass spectrometry and blood biochemistry tests, we measured serum dioxins, fasting glucose, and insulin. Finally, we examined associations between serum dioxin levels and the homoeostasis model assessments of insulin resistance and pancreatic ?-cell function.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Participants with insulin resistance (index at or above the 75th percentile) had higher dioxin levels (24.3 vs. 19.8 pg WHO??-TEQ/g lipid) than those without insulin resistance. In both the crude and adjusted models, insulin resistance increased with serum polychlorinated dibenzo-p-dioxins and dibenzofuran (PCDD/F) levels. We found a slight monotonic increase in insulin resistance across the serum PCDD/F categories (P for the trend <0.001). Groups with serum dioxin levels higher than 20.5 pg WHO??-TEQ/g lipid had higher insulin resistance (adjusted odds ratios of 2.7, 3.5, and 5.0 for 50th to <75th, 75th to <90th, and ?90th percentile, respectively) compared with the reference group (<9.6 pg WHO??-TEQ/g lipid [< 10th percentile]).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: After adjusting for confounding factors, we found a positive association between serum dioxins and the prevalence of insulin resistance.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662811</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Human, animal and cell models support a role for pesticides in the etiology of Parkinson disease. Susceptibility to pesticides may be modified by genetic variants of xenobiotic enzymes, such as paraoxonase, that play a role in metabolizing some organophosphates.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Human, animal and cell models support a role for pesticides in the etiology of Parkinson disease. Susceptibility to pesticides may be modified by genetic variants of xenobiotic enzymes, such as paraoxonase, that play a role in metabolizing some organophosphates.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: We examined associations between Parkinson disease and the organophosphates diazinon, chlorpyrifos, and parathion, and the influence of a functional polymorphism at position 55 in the coding region of the PON1 gene (PON1-55). From 1 January 2001 through 1 January 2008, we recruited 351 incident cases and 363 controls from 3 rural California counties in a population-based case-control study. Participants provided a DNA sample, and residential exposure to organophosphates was determined from pesticide usage reports and a geographic information system (GIS) approach. We assessed the main effects of both genes and pesticides in unconditional logistic regression analyses, and evaluated the effect of carrying a PON1-55 MM variant on estimates of effects for diazinon, chlorpyrifos, and parathion exposures.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Carriers of the variant MM PON1-55 genotype exposed to organophosphates exhibited a greater than 2-fold increase in Parkinson disease risk compared with persons who had the wildtype or heterozygous genotype and no exposure (for diazinon, odds ratio = 2.2 [95% confidence interval = 1.1–4.5]; for chlorpyrifos, 2.6 [1.3–5.4]). The effect estimate for chlorpyrifos, was more pronounced in younger-onset cases and controls (?60 years) (5.3 [1.7–1.6]). No increase in risk was noted for parathion.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: The increase in risk we observed among PON1-55 variant carriers for specific organophosphates metabolized by PON1 underscores the importance of considering susceptibility factors when studying environmental exposures in Parkinson disease.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662807</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: An adequate iodine intake during pregnancy is essential for the synthesis of maternal thyroid hormones and normal brain development in the fetus. Scant evidence is available on the effects and safety of iodine supplementation during pregnancy in areas with adequate or mildly deficient iodine intake. We examined the association of maternal iodine intake and supplementation with thyroid function before 24 weeks of gestation in population-based samples from 3 different areas in Spain.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: An adequate iodine intake during pregnancy is essential for the synthesis of maternal thyroid hormones and normal brain development in the fetus. Scant evidence is available on the effects and safety of iodine supplementation during pregnancy in areas with adequate or mildly deficient iodine intake. We examined the association of maternal iodine intake and supplementation with thyroid function before 24 weeks of gestation in population-based samples from 3 different areas in Spain.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: A cross-sectional study of 1844 pregnant women (gestational age range 8–23 weeks) was carried out in 3 areas in Spain (Guipúzcoa, Sabadell, Valencia), during the period 2004–2008. We measured levels of free thyroxine and thyroid-stimulating hormone (TSH) in serum, iodine in a spot urine sample, and questionnaire estimates of iodine intake from diet, iodized salt and supplements. Adjusted associations were assessed by multiple linear regression and logistic regression analyses.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: There was an increased risk of TSH above 3 ?U/mL in women who consumed 200 ?g or more of iodine supplements daily compared with those who consumed less than 100 ?g/day (adjusted odds ratio = 2.5 [95% confidence interval = 1.2 to 5.4]). We observed no association between urinary iodine and TSH levels. Pregnant women from the area with the highest median urinary iodine (168 ?g/L) and highest supplement coverage (93%) showed the lowest values of serum free thyroxine. (geometric mean = 10.09 pmol/L [9.98 to 10.19]).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Iodine supplement intake in the first half of pregnancy may lead to maternal thyroid dysfunction in iodine-sufficient or mildly iodine-deficient populations.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662808</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Lower intelligence is a risk factor for several specific mental disorders. It is unclear whether it is a risk factor for all mental disorders, and whether it might be associated with illness severity. We examined the relation of premorbid intelligence with risk of hospital admission and with total admission rates, for the whole range of mental disorders.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Lower intelligence is a risk factor for several specific mental disorders. It is unclear whether it is a risk factor for all mental disorders, and whether it might be associated with illness severity. We examined the relation of premorbid intelligence with risk of hospital admission and with total admission rates, for the whole range of mental disorders.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Participants were 1,049,663 Swedish men who took tests of intelligence on conscription into military service and were followed up with regard to hospital admissions for mental disorder, for a mean of 22.6 years. International Classification of Diseases diagnoses were recorded at discharge from the hospital.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Risk of hospital admission for all categories of mental disorder rose with each point decrease in the 9-point IQ score. For a standard deviation decrease in IQ, age-adjusted hazard ratios (95% confidence interval) were 1.60 for schizophrenia (1.55–1.65), 1.49 for other nonaffective psychoses (1.45–1.53), 1.50 for mood disorders (1.47–1.51), 1.51 for neurotic disorders (1.48–1.54), 1.60 for adjustment disorders (1.56–1.64), 1.75 for personality disorders (1.70–1.80), 1.75 for alcohol-related (1.73–1.77), and 1.85 for other substance-use disorders (1.82–1.88). Lower intelligence was also associated with greater comorbidity. Associations changed little on adjustment for potential confounders. Men with lower intelligence had higher total admission rates for mental disorders, a possible marker of clinical severity.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Lower intelligence is a risk factor for the whole range of mental disorders and for illness severity.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662809</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Cross-sectional studies have shown an association between vascular brain disease and depression. Longitudinal data are scarce. In a population-based study we investigated this relationship both cross-sectionally and longitudinally.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Cross-sectional studies have shown an association between vascular brain disease and depression. Longitudinal data are scarce. In a population-based study we investigated this relationship both cross-sectionally and longitudinally.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: Brain MRIs were administered to 479 persons aged 60–90 years at baseline (1995–1996). Brain atrophy, white matter lesions and brain infarcts are all markers of vascular brain disease. At baseline and at follow-up examinations, we also identified persons with depressive symptoms and syndromes using the Center for Epidemiological Studies Depression Scale and psychiatric interviews. Medical records were continuously monitored to identify incident depression. Follow-up was complete until October 2005.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: At baseline, 36 persons had depressive symptoms. Brain atrophy, white matter lesions, and infarcts were associated with presence of depressive symptoms. During follow-up, 92 persons developed depressive symptoms, 35 of whom were categorized as having depressive syndrome. There was no association of any MRI marker with incident depressive symptoms or syndromes.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: Markers of vascular brain disease were associated with depression cross-sectionally. However, when these markers and risk of depression were assessed longitudinally, no relationship was found.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25662818</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>The performance of prediction models can be assessed using a variety of methods and metrics. Traditional measures for binary and survival outcomes include the Brier score to indicate overall model performance, the concordance (or c) statistic for discriminative ability (or area under the receiver operating characteristic [ROC] curve), and goodness-of-fit statistics for calibration.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>The performance of prediction models can be assessed using a variety of methods and metrics. Traditional measures for binary and survival outcomes include the Brier score to indicate overall model performance, the concordance (or c) statistic for discriminative ability (or area under the receiver operating characteristic [ROC] curve), and goodness-of-fit statistics for calibration.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Several new measures have recently been proposed that can be seen as refinements of discrimination measures, including variants of the c statistic for survival, reclassification tables, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Moreover, decision—analytic measures have been proposed, including decision curves to plot the net benefit achieved by making decisions based on model predictions.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>We aimed to define the role of these relatively novel approaches in the evaluation of the performance of prediction models. For illustration, we present a case study of predicting the presence of residual tumor versus benign tissue in patients with testicular cancer (n = 544 for model development, n = 273 for external validation).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>We suggest that reporting discrimination and calibration will always be important for a prediction model. Decision-analytic measures should be reported if the predictive model is to be used for clinical decisions. Other measures of performance may be warranted in specific applications, such as reclassification metrics to gain insight into the value of adding a novel predictor to an established model.</TD></TR></table>
				
		</td>
		</tr>
	</table>		
</body>
</html>
